64 related articles for article (PubMed ID: 27626786)
1. Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer.
Barzegar Behrooz A; Nabavizadeh F; Adiban J; Shafiee Ardestani M; Vahabpour R; Aghasadeghi MR; Sohanaki H
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):41-51. PubMed ID: 27626786
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
[TBL] [Abstract][Full Text] [Related]
3. Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets.
Murphy EM; Centner CS; Bates PJ; Malik MT; Kopechek JA
PLoS One; 2020; 15(5):e0233466. PubMed ID: 32437399
[TBL] [Abstract][Full Text] [Related]
4. Surface modification of hollow gold nanoparticles conducted by incorporating cancer cell membrane and AS1411 aptamer, aiming to achieve a dual-targeted therapy for colorectal cancer.
Hassibian S; Taghdisi SM; Jamshidi Z; Samie A; Alinezhad Nameghi M; Shayan M; Farrokhi N; Alibolandi M; Ramezani M; Dehnavi SM; Abnous K
Int J Pharm; 2024 Apr; 655():124036. PubMed ID: 38522491
[TBL] [Abstract][Full Text] [Related]
5. AS1411aptamer conjugated liposomes for targeted delivery of arsenic trioxide in mouse xenograft model of melanoma cancer.
Shariat Razavi F; Kouchak M; Sistani Karampour N; Mahdavinia M; Nazari Khorasgani Z; Rezaie A; Rahbar N
J Liposome Res; 2024 Jun; 34(2):288-302. PubMed ID: 37843918
[TBL] [Abstract][Full Text] [Related]
6. Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy.
Yang Y; Han Y; Sun Q; Cheng J; Yue C; Liu Y; Song J; Jin W; Ding X; de la Fuente JM; Ni J; Wang X; Cui D
J Nanobiotechnology; 2021 Feb; 19(1):54. PubMed ID: 33627152
[TBL] [Abstract][Full Text] [Related]
7. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
8. Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts.
Niu B; Wu Y; Zhou M; Lin R; Ge P; Chen X; Zhou H; Zhang X; Xie J
Cancer Lett; 2023 Nov; 579():216461. PubMed ID: 37898358
[TBL] [Abstract][Full Text] [Related]
9. Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery.
Zhao X; Xi Y; Zhang Y; Wu Q; Meng R; Zheng B; Rei L
Nanoscale Res Lett; 2019 Aug; 14(1):273. PubMed ID: 31414279
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-Functionalized Gold Nanoparticles for Drug Delivery to Gynecological Carcinoma Cells.
Lopes-Nunes J; Agonia AS; Rosado T; Gallardo E; Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Fonseca-Moutinho J; Campello MPC; Paiva A; Paulo A; Vulgamott A; Ellignton AD; Oliveira PA; Cruz C
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439193
[TBL] [Abstract][Full Text] [Related]
11. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 May; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
12. Formulation optimization of lyophilized aptamer-gold nanoparticles: Maintained colloidal stability and cellular uptake.
Saidi D; Obeidat M; Alsotari S; Ibrahim AA; Al-Buqain R; Wehaibi S; Alqudah DA; Nsairat H; Alshaer W; Alkilany AM
Heliyon; 2024 May; 10(10):e30743. PubMed ID: 38774322
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-assisted tumor localization of bacteria for enhanced biotherapy.
Geng Z; Cao Z; Liu R; Liu K; Liu J; Tan W
Nat Commun; 2021 Nov; 12(1):6584. PubMed ID: 34782610
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Functionalized Liposomes as a Potential Treatment for Basal Cell Carcinoma.
Cadinoiu AN; Rata DM; Atanase LI; Daraba OM; Gherghel D; Vochita G; Popa M
Polymers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540426
[TBL] [Abstract][Full Text] [Related]
15. Engineering a customized nanodrug delivery system at the cellular level for targeted cancer therapy.
Li J; Qiu L; Xie S; Zhang J; Zhang L; Liu H; Li J; Zhang X; Tan W
Sci China Chem; 2018 Apr; 61(4):497-504. PubMed ID: 30271427
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to Journal of Pharmaceutical Sciences Volume 110 (2021) 2946-2954.
Wang H; Chen W; Wu G; Kong J; Yuan S; Chen L
J Pharm Sci; 2024 Jun; 113(6):1690-1692. PubMed ID: 38554930
[No Abstract] [Full Text] [Related]
17. "Sense-and-Treat" DNA Nanodevice for Synergetic Destruction of Circulating Tumor Cells.
Chen N; Qin S; Yang X; Wang Q; Huang J; Wang K
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26552-26558. PubMed ID: 27653943
[TBL] [Abstract][Full Text] [Related]
18. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery.
Narwade M; Shaikh A; Gajbhiye KR; Kesharwani P; Gajbhiye V
Biomater Res; 2023 May; 27(1):42. PubMed ID: 37149607
[TBL] [Abstract][Full Text] [Related]
19. DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.
Shishparenok AN; Furman VV; Zhdanov DD
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046816
[TBL] [Abstract][Full Text] [Related]
20. Construction of Stomach Cancer Lesion Detection Combined with Drug Therapy Based on Artificial Intelligence.
Zhai S; Yu L; Li J
Contrast Media Mol Imaging; 2022; 2022():1905437. PubMed ID: 36304779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
